{"timestamp": 1771609001.918905, "value": {"ticker": "ORMP", "company_name": "Oramed Pharmaceuticals Inc.", "short_name": "Oramed Pharmaceuticals Inc.", "sector": "Healthcare", "industry": "Biotechnology", "country": "United States", "market_cap": 129706000, "float_shares": 29155696, "shares_outstanding": 39802455, "short_ratio": 2.08, "short_percent_of_float": 0.0187, "shares_short": 644912, "shares_short_prior": 424089, "insider_percent_held": 0.14932, "institution_percent_held": 0.23010999, "total_cash": 134687008, "total_debt": 860000, "total_revenue": 2000000, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 21.926, "gross_margins": 0.0064999997, "operating_margins": -6.5055, "debt_to_equity": 0.425, "current_ratio": 22.245, "book_value": 4.978, "price_to_book": 0.6538771, "operating_cashflow": -10590000, "free_cashflow": -3228875, "price": 3.255, "52w_high": 3.71, "52w_low": 1.82, "avg_volume": 237720, "avg_volume_10d": 144680, "full_time_employees": 0, "audit_risk": 0, "overall_risk": 0}}